We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

HYD Receives Approval for Phase 2 Clinical Trial

News   Jul 19, 2016

 
HYD Receives Approval for Phase 2 Clinical Trial
 
 
 

RELATED ARTICLES

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

Using AI to ID Lung Cancer Types

News

A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE